过度表达Dyrk1A通过调节小鼠的血纤维素和纤维素原水平来影响出血
Guillaume Postic1, Jean Solarz2, Cécile Loubière2
1Université Paris Cité, BFA, UMR 8251, CNRS, ERLU1133, Paris, France.
Journal of cellular and molecular medicine
|July 7, 2023
概括
唐氏综合征与血小板数量低,但出血减少有关. 在小鼠中过度表达Dyrk1A模仿了这一点,由于纤维素和纤维素原的增加,出血时间较短.
科学领域:
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 唐氏综合征是人类最常见的染色体异常.
- 患者经常表现出血液学疾病,特别是轻度至中度的血小板缺血 (血小板数量低).
- 与唐氏综合征相关的血小板缺血及其与出血风险的分离背后的分子机制尚不清楚.
研究的目的:
- 在小鼠模型中研究Dyrk1A过度表达对血小板数和出血时间的影响.
- 探索连接Dyrk1A,血小板功能和血液静止的分子机制.
主要方法:
- 对过度表达Dyrk1A的小鼠进行了血小板计数和出血时间分析.
- 通过受体表达,激活试验 (ADP,血栓,),循环激活血小板分析和血小板半衰期测量来评估血小板功能.
- 进行了Dyrk1A互原子网络分析.
- 量化了纤维素和纤维素的血水平,并检查了肝脏纤维素的产生.
主要成果:
- 过度表达Dyrk1A的小鼠显示血小板数量减少了20%,出血时间减少了50%.
- 血小板缩和减少出血与异常的血小板受体,激活缺陷,循环激活血小板或改变血小板半衰期无关.
- 网络分析揭示了Dyrk1A,纤维素和纤维素因子之间通过蛋白质集群的间接相互作用.
- 过度表达Dyrk1A导致了血纤维素和纤维素原水平的增加,与增强的肝脏纤维素原产量有关.
结论:
- 在小鼠中过度表达Dyrk1A导致出血时间减少,独立于典型的血小板功能障碍.
- 由于肝脏产量增加,血纤维素和纤维素水平的增加似乎介导了降低的出血表型.
- 这项研究揭示了Dyrk1A在血液静止中通过其与纤维素和纤维素原的间接相互作用发挥的新型作用.
相关概念视频
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Disorders of Hemostasis
1.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.0K


